Italo Luis da Silva, Hanqi Yan, Yujing Wang +3cs.IR cs.CL
Scientific papers may relate by problem, method, result, or contribution, but document-level retrievers collapse these into a single similarity score without saying why they are related. Citation- and similarity-based retrieval alone also confines search to the neighbourhood of what is already known, whereas generative retrieval generates document identifiers directly, enabling the exploratory retrieval that scientific discovery depends on. We connect papers in a graph whose edges are typed by these four facets, derived from facet items and citation signals, and distil it into a generative retriever whose identifiers are the papers' own facet text. Two graph properties do not survive naive distillation. First, because every training pair is an edge, naive enumeration indexes just 84% of the corpus. Coverage-aware distillation makes every paper learnable through a reverse-neighbour fallback, a minimum-coverage threshold, and edge-importance weighting. Second, constrained decoding guarantees that every generated identifier is a valid paper, but not that the graph connects it to the query. Graph-weighted reciprocal rank fusion scales each candidate's rank term by its query-candidate edge weight, dropping unsupported ones. On LitWeave, our constructed corpus of 11,359 NLP papers, Graft recovers 91% of its graph teacher's Recall@20 with no nearest-neighbour index or encoder at inference, and outperforms the graph teacher on query papers outside the corpus. It reproduces the graph's own facet labels at 0.922 precision, so every returned paper arrives labelled with the facet that surfaced it rather than an opaque score.
Large language model (LLM) agents can support medication review between clinical visits, but safe choices for older adults with multimorbidity depend on conditions, medications, and geriatric risks that users may omit. We introduce ATLAS, a coupled graph--policy distillation framework for patient-adaptive medication safety. ATLAS structures guideline evidence as a medication-safety graph. Targeted questions update the patient state and distill relevant relations into a patient-specific medication conflict graph (PMCG). A risk-first multi-agent policy uses the PMCG to screen contraindications, assess cautions and monitoring needs, identify safer alternatives, and verify the final medication plan. We also introduce GeriMedBench, an interactive benchmark that tests safety-critical information acquisition and evidence-based decision revision. Across a European non-interactive multimorbidity benchmark, an Asian interactive multimorbidity benchmark, and an Asian non-interactive cross-guideline benchmark, ATLAS achieves the strongest complete-decision performance among the compared systems. On the European non-interactive multimorbidity benchmark, it exceeds the strongest proprietary LLM baseline by 53.73 points in Strict Success Rate and 14.63 points in overall safety reasoning score (OSRS), with no unsafe recommendations under the automated evaluator. A blinded clinician evaluation gives ATLAS higher mean ratings across all five criteria and flags potentially unsafe recommendations in one ATLAS case and two Gemini cases.